Preclinical Department, Andalusian Network for Advanced Therapies, Fundación Progreso y Salud, Sevilla, Spain.
Barcelona Biomedical Research Parc (PRBB), Barcelona, Spain.
Crit Rev Biotechnol. 2020 May;40(3):283-291. doi: 10.1080/07388551.2019.1679084. Epub 2020 Feb 13.
Recent advances in stem cell biology and molecular engineering have improved and simplified the methodology employed to create experimental chimeras, highlighting their value in basic research and broadening the spectrum of potential applications. Experimental chimeras have been used for decades during the generation of murine genetic models, this being especially relevant in developmental and regeneration studies. Indeed, their value for the research and modeling of human diseases was recognized by the 2007 Nobel Prize to Mario Capecchi, Martin Evans, and Oliver Smithies. More recently, their potential application in regenerative medicine has generated a lot of interest, particularly the enticing possibility to generate human organs for transplantation in livestock animals. In this review, we provide an update on interspecific chimeric organogenesis, its possibilities, current limitations, alternatives, and ethical issues.
近年来,干细胞生物学和分子工程的进展提高并简化了创建实验嵌合体所采用的方法,突出了它们在基础研究中的价值,并拓宽了潜在应用的范围。实验嵌合体在生成小鼠遗传模型的几十年中得到了应用,这在发育和再生研究中尤为重要。事实上,它们在研究和模拟人类疾病方面的价值得到了 2007 年诺贝尔生理学或医学奖得主马里奥·卡佩奇、马丁·埃文斯和奥利弗·史密斯的认可。最近,它们在再生医学中的潜在应用引起了广泛关注,特别是在牲畜中生成可用于移植的人类器官的诱人可能性。在这篇综述中,我们提供了关于种间嵌合器官发生及其可能性、当前限制、替代方案和伦理问题的最新信息。